<DOC>
	<DOCNO>NCT02525796</DOCNO>
	<brief_summary>This study evaluate whether block mineralocorticoid receptor , alone , combination calcimimetic cinacalcet , low parathyroid hormone calcium level primary hyperparathyroidism .</brief_summary>
	<brief_title>Evaluating Alternative Medical Therapies Primary Hyperparathyroidism</brief_title>
	<detailed_description>To conduct double-blinded , placebo-controlled , randomize intervention study investigate whether mineralocorticoid receptor ( MR ) antagonism , alone combination cinacalcet , effective therapy primary hyperparathyroidism ( P-HPTH ) . Hypothesis : MR antagonism , monotherapy combination calcimimetic , mechanism lower parathyroid hormone ( PTH ) primary hyperparathyroidism ( P-HPTH ) . Study Design : Sixty subject P-HPTH enrol randomly receive eplerenone ( potassium-sparing diuretic directly block MR ) , amiloride ( potassium-sparing diuretic directly block MR ) , placebo 4 week . Thereafter , subject receive cinacalcet therapy ( calcimimetic lower PTH ) addition randomize intervention additional 2 week . Anticipated Results : In proof-of-concept study , eplerenone therapy lower PTH , serum calcium , marker bone resorption P-HPTH , compare placebo . The PTH response amiloride resemble placebo , suggest eplerenone mediate reduction PTH specific interaction MR . Combination therapy eplerenone + cinacalcet result additive synergistic reduction PTH , compare placebo + cinacalcet placebo + amiloride . Implications : MR antagonism ( alone combination cinacalcet ) may mechanism low PTH calcium P-HPTH , thereby identify new potential option limit medical therapy P-HPTH .</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>physician diagnosis active PHPTH ( Serum calcium &gt; upper limit reference range serum PTH &gt; ULRR ; Serum Calcium &gt; ULRR AND serum PTH &gt; 30 pg/mL ; Serum Calcium within 0.2 mg/dL ULRR PTH &gt; ULRR ) . negative pregnancy test woman age 1845 estimate glomerular filtration rate &lt; 60mL/min/1,73m2 serum potassium &gt; 5.0 mmol/L age &lt; 18 &gt; 80 year diabetes well control ( HbA1c &gt; 8 % ) \ liver failure heart failure history myocardial infarction stroke active use lithium active chronic inflammatory condition ( inflammatory bowel disease , rheumatoid arthritis , sarcoidosis ) initiation within 3 month bisphosphonates cinacalcet need imminent parathyroidectomy ( within next 68 week ) determine endocrinologist surgeon absolute serum calcium &gt; 13.0 mg/dL positive pregnancy test study visit woman age 1845 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>